Randomized Controlled Trial
Copyright ©The Author(s) 2022.
World J Gastroenterol. Nov 28, 2022; 28(44): 6294-6309
Published online Nov 28, 2022. doi: 10.3748/wjg.v28.i44.6294
Figure 4
Figure 4 Changes from baseline in serum gastrin levels at weeks 4 and 8 (per-protocol set).

  • Citation: Lee KN, Lee OY, Chun HJ, Kim JI, Kim SK, Lee SW, Park KS, Lee KL, Choi SC, Jang JY, Kim GH, Sung IK, Park MI, Kwon JG, Kim N, Kim JJ, Lee ST, Kim HS, Kim KB, Lee YC, Choi MG, Lee JS, Jung HY, Lee KJ, Kim JH, Chung H. Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis. World J Gastroenterol 2022; 28(44): 6294-6309
  • URL: https://www.wjgnet.com/1007-9327/full/v28/i44/6294.htm
  • DOI: https://dx.doi.org/10.3748/wjg.v28.i44.6294